Richney, I am also a long term holder and very surprised to read your comments on relevant historical tests. A quick review of company releases over a long period indicates to me that
- Airsonea, the previous version of Wheezo, never received FDA approval
-Airsonea was never "successfully tested" against spirometry, nor has Wheezo yet
- Airsonea achieved an 85% correlation with physicians using stethoscopes in 2016 , yet in 2020 RSH said Wheezo got only 46% in detecting wheeze before adjusting results.
IMO you are incorrect. If you have different company information please let all of us know how to find it. That would be helpful and encouraging.
Cheers
Stern
Product tests & clinical results, facts please
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.80M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 633000 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 60000 | 2 |
View Market Depth
| Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable